AAAAAA
Results: 26-50/64
Authors:
LECRUBIER Y
BOURIN M
MOON CAL
SCHIFANO F
BLANCHARD C
DANJOU P
HACKETT D
Citation: Y. Lecrubier et al., EFFICACY OF VENLAFAXINE IN DEPRESSIVE-ILLNESS IN GENERAL-PRACTICE, Acta psychiatrica Scandinavica, 95(6), 1997, pp. 485-493
Authors:
BOURIN M
HASCOET M
COLOMBEL MC
REDROBE JP
BAKER GB
Citation: M. Bourin et al., DIFFERENTIAL-EFFECTS OF CLONIDINE, LITHIUM AND QUININE IN THE FORCED SWIMMING TEST IN MICE FOR ANTIDEPRESSANTS - POSSIBLE ROLES OF SEROTONINERGIC SYSTEMS, European neuropsychopharmacology, 6(3), 1996, pp. 231-236
Authors:
BOURIN M
BAKER GB
Citation: M. Bourin et Gb. Baker, DO G-PROTEINS HAVE A ROLE IN ANTIDEPRESSANT ACTIONS, European neuropsychopharmacology, 6(1), 1996, pp. 49-53
Authors:
REDROBE JP
PINOT P
BOURIN M
Citation: Jp. Redrobe et al., THE EFFECT OF THE POTASSIUM CHANNEL ACTIVATOR, CROMAKALIM, ON ANTIDEPRESSANT DRUGS IN THE FORCED SWIMMING TEST IN MICE, Fundamental and clinical pharmacology, 10(6), 1996, pp. 524-528
Authors:
BOURIN M
HASCOET M
DEGUIRAL P
Citation: M. Bourin et al., 5-HTP INDUCED DIARRHEA AS A CARCINOID-SYNDROME MODEL IN MICE, Fundamental and clinical pharmacology, 10(5), 1996, pp. 450-457
Authors:
BOURIN M
MALINGE M
VASAR E
BRADWEJN J
Citation: M. Bourin et al., 2 FACES OF CHOLECYSTOKININ - ANXIETY AND SCHIZOPHRENIA, Fundamental and clinical pharmacology, 10(2), 1996, pp. 116-126
Authors:
BOURIN M
BAKER GB
Citation: M. Bourin et Gb. Baker, THE FUTURE OF ANTIDEPRESSANTS, Biomedicine & pharmacotherapy, 50(1), 1996, pp. 7-12
Authors:
BOURIN M
REDROBE JP
HASCOET M
BAKER GB
COLOMBEL MC
Citation: M. Bourin et al., A SCHEMATIC REPRESENTATION OF THE PSYCHOPHARMACOLOGICAL PROFILE OF ANTIDEPRESSANTS, Progress in neuro-psychopharmacology & biological psychiatry, 20(8), 1996, pp. 1389-1402
Authors:
BOURIN M
MALINGE M
Citation: M. Bourin et M. Malinge, A NEW DESIGN OF TRIAL FOR HYPNOTICS COMPARISON - A DOUBLE-BLIND CROSS-OVER TRIAL WITH PATIENTS PREFERENCE ASSESSMENT AND CONTINUATION OF THE PREFERRED TREATMENT, Progress in neuro-psychopharmacology & biological psychiatry, 20(3), 1996, pp. 373-385
Authors:
VOLKE V
SOOSAAR A
KOKS S
BOURIN M
MANNISTO PT
VASAR E
Citation: V. Volke et al., NITRIC-OXIDE MEDIATES CERULEIN-INDUCED SUPPRESSION OF LOCOMOTOR-ACTIVITY, Neuropeptides, 30(4), 1996, pp. 323-326
Authors:
GUO WY
TODD K
BOURIN M
HASCOET M
KOUADIO F
Citation: Wy. Guo et al., ADDITIVE EFFECTS OF GLYBURIDE AND ANTIDEPRESSANTS IN THE FORCED SWIMMING TEST - EVIDENCE FOR THE INVOLVEMENT OF POTASSIUM CHANNEL BLOCKADE, Pharmacology, biochemistry and behavior, 54(4), 1996, pp. 725-730
Authors:
BOISSEL JP
AUTRET E
BECHTEL P
BOURIN M
FUNKBRENTANO C
LIEVRE M
PAINTAUD G
PONS G
Citation: Jp. Boissel et al., METHODS FOR DRAFTING A LIST OF EDUCATIONA L-OBJECTIVES - A PRACTICAL CASE IN PHARMACOLOGY, Therapie, 51(6), 1996, pp. 655-666
Authors:
DUBOIS B
STEHLE B
LEHNER JP
DEROUESNE C
BOURIN M
LAMOUR Y
BLIN O
JOURDAIN G
ALPEROVITCH A
ALLARD M
BILLARDON M
CATTELIN F
CHILDS M
DELACOURTE M
DELALLEAU B
DIGIAMBERARDINO L
EMRE M
GENTHON R
GONI S
JAFFARD R
LACOMBLEZ L
LEBERT F
LEGER JM
MAHIEUX F
MICHEL B
PARTIOT A
PASQUIER F
PAUL HPS
PUECH A
REIGNEAU O
RENAULT S
SCHLENCK A
Citation: B. Dubois et al., METHODOLOGY FOR DEVELOPING DRUGS IN ALZHE IMER-DISEASE, Therapie, 51(4), 1996, pp. 444-448
Authors:
BOURIN M
JOLLIET P
Citation: M. Bourin et P. Jolliet, REVIEWING THE INITIAL ESTABLISHMENT OF TE ACHING OF PHARMACOLOGY - QUALITY VERSUS QUANTITY OF KNOWLEDGE, HESITATION IS NO LONGER POSSIBLE, Therapie, 51(3), 1996, pp. 298-301
Authors:
REDROBE JP
MACSWEENEY CP
BOURIN M
Citation: Jp. Redrobe et al., THE ROLE OF 5-HT1A AND 5-HT1B RECEPTORS IN ANTIDEPRESSANT DRUG ACTIONS IN THE MOUSE FORCED SWIMMING TEST, European journal of pharmacology, 318(2-3), 1996, pp. 213-220
Authors:
BOURIN M
Citation: M. Bourin, VILLAGES AND VILLAGERS IN THE MIDDLE-AGES - FRENCH - FOSSIER,R, Cahiers de civilisation medievale, 39, 1996, pp. 383-385
Authors:
GUO WY
TODD KG
BOURIN M
HASCOET M
Citation: Wy. Guo et al., THE ADDITIVE EFFECTS OF QUININE ON ANTIDEPRESSANT DRUGS IN THE FORCEDSWIMMING TEST IN MICE, Psychopharmacology, 121(2), 1995, pp. 173-179
Authors:
VOLKE V
KOKS S
VASAR E
BOURIN M
BRADWEJN J
MANNISTO PT
Citation: V. Volke et al., INHIBITION OF NITRIC-OXIDE SYNTHASE CAUSES ANXIOLYTIC-LIKE BEHAVIOR IN AN ELEVATED PLUS-MAZE, NeuroReport, 6(10), 1995, pp. 1413-1416
Authors:
HASCOET M
BOURIN M
PAYEUR R
LOMBET A
PEGLION JL
Citation: M. Hascoet et al., SIGMA-LIGAND S14905 AND LOCOMOTOR-ACTIVITY IN MICE, European neuropsychopharmacology, 5(4), 1995, pp. 481-489
Authors:
BOURIN M
LEMELLEDO JM
MALINGE M
Citation: M. Bourin et al., EXPERIMENTAL AND CLINICAL-PHARMACOLOGY OF PSYCHOSTIMULANTS, Canadian journal of psychiatry, 40(7), 1995, pp. 401-410
Authors:
BOURIN M
MALINGE M
Citation: M. Bourin et M. Malinge, CONTROLLED COMPARISON OF THE EFFECTS AND ABRUPT DISCONTINUATION OF BUSPIRONE AND LORAZEPAM, Progress in neuro-psychopharmacology & biological psychiatry, 19(4), 1995, pp. 567-575
Authors:
BOURIN M
COLOMBEL MC
MALINGE M
Citation: M. Bourin et al., LORAZEPAM 0.25MG TWICE A DAY IMPROVES ASPECTS OF PSYCHOMETRIC PERFORMANCE IN HEALTHY-VOLUNTEERS, J PSYCHOPH, 9(3), 1995, pp. 251-257
Authors:
BOURIN M
MALINGE M
GUITTON B
Citation: M. Bourin et al., PROVOCATIVE AGENTS IN PANIC DISORDER, Therapie, 50(4), 1995, pp. 301-306
Authors:
BOURIN M
ALLAIN H
ATASSI G
BLANCHARD JC
BLIN O
BOST PE
BRAQUET P
CHAUMETRIFFAUD D
DANGUMAU J
ELIA AF
HOUDEBINE LM
LECHAT P
LECOMTE JM
LEFUR G
LEHNER JP
MARSAC J
PETIT P
SASSARD J
SYROTA A
VILAINE JP
Citation: M. Bourin et al., THE FUTURE OF PHARMACOLOGICAL MODELS, Therapie, 50(4), 1995, pp. 375-379
Authors:
LANG A
HARRO J
SOOSAAR A
KOKS S
VOLKE V
ORELAND L
BOURIN M
VASAR E
BRADWEJN J
MANNISTO PT
Citation: A. Lang et al., ROLE OF N-METHYL-D-ASPARTIC ACID AND CHOLECYSTOKININ RECEPTORS IN APOMORPHINE-INDUCED AGGRESSIVE-BEHAVIOR IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 351(4), 1995, pp. 363-370